Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hye Seung Nam

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Computational and Structural Biotechnology Journal|November 16, 2022
Reprogramming landscape highlighted by dynamic transcriptomes in therapy-induced neuroendocrine differentiationAndrew Michael Asberry, Sheng Liu, Hye Seung Nam, et al.
The Prostate|July 18, 2025
PRMT5:MEP50 Are Mediators of Treatment-Induced Neuroendocrine Differentiation in Prostate CancerHye Seung Nam, Andrew Michael Asberry, Xuehong Deng, et al.
Journal of Medicinal Chemistry|May 1, 2026
Tailoring PRMT Inhibition: Shifting PRMT7 Selectivity to PRMT4 through "T-Shape" Strategy and "Linker-Specific" PreferencesAkshay S Kulkarni, Youchao Deng, Hye Seung Nam, et al.
Cell Death & Disease|February 21, 2018
Elevated intracellular cAMP exacerbates vulnerability to oxidative stress in optic nerve head astrocytesMyoung Sup Shim, Keun-Young Kim, Jung Hyun Bu, et al.
Briefings in Bioinformatics|September 25, 2024
CDHu40: a novel marker gene set of neuroendocrine prostate cancerSheng Liu, Hye Seung Nam, Ziyu Zeng, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
CDHu40: a novel marker gene set of neuroendocrine prostate cancer (NEPC)Sheng Liu, Hye Seung Nam, Ziyu Zeng, et al.
Oncogene|March 10, 2026
Cereblon (CRBN) inhibits prostate cancer metastasis by negatively regulating 6-phosphogluconate dehydrogenase (6PGD)Koushik Guchhait, Hyeon-Seung Yoon, Hyun-Su An, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Computational and Structural Biotechnology Journal|November 16, 2022
Reprogramming landscape highlighted by dynamic transcriptomes in therapy-induced neuroendocrine differentiationAndrew Michael Asberry, Sheng Liu, Hye Seung Nam, et al.
The Prostate|July 18, 2025
PRMT5:MEP50 Are Mediators of Treatment-Induced Neuroendocrine Differentiation in Prostate CancerHye Seung Nam, Andrew Michael Asberry, Xuehong Deng, et al.
Journal of Medicinal Chemistry|May 1, 2026
Tailoring PRMT Inhibition: Shifting PRMT7 Selectivity to PRMT4 through "T-Shape" Strategy and "Linker-Specific" PreferencesAkshay S Kulkarni, Youchao Deng, Hye Seung Nam, et al.
Cell Death & Disease|February 21, 2018
Elevated intracellular cAMP exacerbates vulnerability to oxidative stress in optic nerve head astrocytesMyoung Sup Shim, Keun-Young Kim, Jung Hyun Bu, et al.
Briefings in Bioinformatics|September 25, 2024
CDHu40: a novel marker gene set of neuroendocrine prostate cancerSheng Liu, Hye Seung Nam, Ziyu Zeng, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
CDHu40: a novel marker gene set of neuroendocrine prostate cancer (NEPC)Sheng Liu, Hye Seung Nam, Ziyu Zeng, et al.
Oncogene|March 10, 2026
Cereblon (CRBN) inhibits prostate cancer metastasis by negatively regulating 6-phosphogluconate dehydrogenase (6PGD)Koushik Guchhait, Hyeon-Seung Yoon, Hyun-Su An, et al.
Pageof 1